Synergistic effects of APOE and sex on the gut microbiome of young EFAD transgenic mice
暂无分享,去创建一个
[1] Huidong Tang,et al. Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota , 2019, Alzheimer's & Dementia.
[2] Juan Maldonado Weng,et al. The role of APOE in transgenic mouse models of AD , 2019, Neuroscience Letters.
[3] Molly Fox,et al. Alzheimer's disease and symbiotic microbiota: an evolutionary medicine perspective , 2019, Annals of the New York Academy of Sciences.
[4] Lanjuan Li,et al. Altered microbiomes distinguish Alzheimer’s disease from amnestic mild cognitive impairment and health in a Chinese cohort , 2019, Brain, Behavior, and Immunity.
[5] J. Hort,et al. Antibiotics, gut microbiota, and Alzheimer’s disease , 2019, Journal of Neuroinflammation.
[6] J. Gilbert,et al. Sex-specific effects of microbiome perturbations on cerebral Aβ amyloidosis and microglia phenotypes , 2019, The Journal of experimental medicine.
[7] G. Guillemin,et al. Microbiota Alterations in Alzheimer’s Disease: Involvement of the Kynurenine Pathway and Inflammation , 2019, Neurotoxicity Research.
[8] A. Minihane,et al. APOE genotype influences the gut microbiome structure and function in humans and mice: relevance for Alzheimer’s disease pathophysiology , 2019, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[9] T. Unno,et al. Sex Differences in Gut Microbiota , 2019, The world journal of men's health.
[10] Xianlin Han,et al. Altered bile acid profile associates with cognitive impairment in Alzheimer's disease—An emerging role for gut microbiome , 2018, Alzheimer's & Dementia.
[11] H. Sokol,et al. Bilophila wadsworthia aggravates high fat diet induced metabolic dysfunctions in mice , 2018, Nature Communications.
[12] M. Nagarkatti,et al. The role of gut microbiome and associated metabolome in the regulation of neuroinflammation in multiple sclerosis and its implications in attenuating chronic inflammation in other inflammatory and autoimmune disorders , 2018, Immunology.
[13] Huadong Zhou,et al. Gut Microbiota is Altered in Patients with Alzheimer's Disease. , 2018, Journal of Alzheimer's disease : JAD.
[14] Luke R. Thompson,et al. Best practices for analysing microbiomes , 2018, Nature Reviews Microbiology.
[15] P. Iozzo,et al. Microbiome-metabolome signatures in mice genetically prone to develop dementia, fed a normal or fatty diet , 2018, Scientific Reports.
[16] G. Suen,et al. The Ruminococci: key symbionts of the gut ecosystem , 2018, Journal of Microbiology.
[17] S. Bakker,et al. Roles of high apolipoprotein E blood levels and HDL in development of familial dysbetalipoproteinemia in ε2ε2 subjects. , 2017, Clinical biochemistry.
[18] B. Escribano,et al. Interrelationships Among Gut Microbiota and Host: Paradigms, Role in Neurodegenerative Diseases and Future Prospects. , 2018, CNS & neurological disorders drug targets.
[19] A. Jačan,et al. Visceral Inflammation and Immune Activation Stress the Brain , 2017, Front. Immunol..
[20] Rick L. Stevens,et al. A communal catalogue reveals Earth’s multiscale microbial diversity , 2017, Nature.
[21] Sterling C. Johnson,et al. Gut microbiome alterations in Alzheimer’s disease , 2017, Scientific Reports.
[22] M. Herbst-Kralovetz,et al. Estrogen-gut microbiome axis: Physiological and clinical implications. , 2017, Maturitas.
[23] F. O'Gara,et al. Statin therapy causes gut dysbiosis in mice through a PXR-dependent mechanism , 2017, Microbiome.
[24] M. Jorquera,et al. Bacterial Community Profile of the Gut Microbiota Differs between Hypercholesterolemic Subjects and Controls , 2017, BioMed research international.
[25] B. Hamaker,et al. Fiber-utilizing capacity varies in Prevotella- versus Bacteroides-dominated gut microbiota , 2017, Scientific Reports.
[26] M. LaDu,et al. EFAD transgenic mice as a human APOE relevant preclinical model of Alzheimer’s disease[S] , 2017, Journal of Lipid Research.
[27] K. Magori,et al. The chicken or the egg dilemma: intestinal dysbiosis in multiple sclerosis. , 2017, Annals of translational medicine.
[28] Aleksandra A. Kolodziejczyk,et al. Dysbiosis and the immune system , 2017, Nature Reviews Immunology.
[29] G. Frisoni,et al. Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota , 2017, Scientific Reports.
[30] G. Frisoni,et al. Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly , 2017, Neurobiology of Aging.
[31] Bin Zhao,et al. The Gut Microbiota and Alzheimer's Disease. , 2017, Journal of Alzheimer's disease : JAD.
[32] A. Marais,et al. Autosomal dominant familial dysbetalipoproteinemia: A pathophysiological framework and practical approach to diagnosis and therapy. , 2017, Journal of clinical lipidology.
[33] Zeynep Madak-Erdogan,et al. Estrogen and Microbiota Crosstalk: Should We Pay Attention? , 2016, Trends in Endocrinology & Metabolism.
[34] Reetta Satokari,et al. Mucosal Prevalence and Interactions with the Epithelium Indicate Commensalism of Sutterella spp. , 2016, Front. Microbiol..
[35] Ali A. Faruqi,et al. Gut microbiota in early pediatric multiple sclerosis: a case−control study , 2016, European journal of neurology.
[36] K. Hase,et al. The diet-microbiota-metabolite axis regulates the host physiology. , 2016, Journal of biochemistry.
[37] T. Drake,et al. Sex differences and hormonal effects on gut microbiota composition in mice , 2016, Gut microbes.
[38] Laura M Cox,et al. Alterations of the human gut microbiome in multiple sclerosis , 2016, Nature Communications.
[39] Krishna R. Kalari,et al. Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls , 2016, Scientific Reports.
[40] J. Clemente,et al. Intestinal Microbiota Is Influenced by Gender and Body Mass Index , 2016, PloS one.
[41] J. Raes,et al. Faecal Metaproteomic Analysis Reveals a Personalized and Stable Functional Microbiome and Limited Effects of a Probiotic Intervention in Adults , 2016, PloS one.
[42] F. Bäckhed,et al. Interaction between dietary lipids and gut microbiota regulates hepatic cholesterol metabolism1[S] , 2016, Journal of Lipid Research.
[43] T. Bale,et al. Sex differences in the gut microbiome–brain axis across the lifespan , 2016, Philosophical Transactions of the Royal Society B: Biological Sciences.
[44] Ahmed A. Metwally,et al. Analysis of the microbiome: Advantages of whole genome shotgun versus 16S amplicon sequencing. , 2016, Biochemical and biophysical research communications.
[45] J. Raes,et al. Heterogeneity of the gut microbiome in mice: guidelines for optimizing experimental design , 2015, FEMS microbiology reviews.
[46] S. Turroni,et al. High-level adherence to a Mediterranean diet beneficially impacts the gut microbiota and associated metabolome , 2015, Gut.
[47] C. Kahn,et al. Interactions between Gut Microbiota, Host Genetics and Diet Modulate the Predisposition to Obesity and Metabolic Syndrome. , 2015, Cell metabolism.
[48] Matthew L Senjem,et al. Age, Sex, and APOE ε4 Effects on Memory, Brain Structure, and β-Amyloid Across the Adult Life Span. , 2015, JAMA neurology.
[49] J. Goedert,et al. Sex, Body Mass Index, and Dietary Fiber Intake Influence the Human Gut Microbiome , 2015, PloS one.
[50] Pinal N. Kanabar,et al. APOE‐modulated Aβ‐induced neuroinflammation in Alzheimer's disease: current landscape, novel data, and future perspective , 2015, Journal of neurochemistry.
[51] P. Wolf,et al. Gender and incidence of dementia in the Framingham Heart Study from mid-adult life , 2015, Alzheimer's & Dementia.
[52] N. Natarajan,et al. From microbe to man: the role of microbial short chain fatty acid metabolites in host cell biology. , 2014, American journal of physiology. Cell physiology.
[53] P. Bhargava,et al. Gut Microbiome and Multiple Sclerosis , 2014, Current Neurology and Neuroscience Reports.
[54] William A. Walters,et al. Conducting a Microbiome Study , 2014, Cell.
[55] T. Dinan,et al. Minireview: Gut microbiota: the neglected endocrine organ. , 2014, Molecular endocrinology.
[56] Andre Altmann,et al. Sex modifies the APOE‐related risk of developing Alzheimer disease , 2014, Annals of neurology.
[57] Lawrence A. David,et al. Diet rapidly and reproducibly alters the human gut microbiome , 2013, Nature.
[58] J. Cryan,et al. Dealing with ability of the microbiota to influence the brain, and ultimately cognition and behavioral. , 2014, Advances in experimental medicine and biology.
[59] A. Dale,et al. Higher Rates of Decline for Women and Apolipoprotein E ε4 Carriers , 2013, American Journal of Neuroradiology.
[60] Barbara M. Bakker,et al. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism , 2013, Journal of Lipid Research.
[61] Aly A. Khan,et al. Gender bias in autoimmunity is influenced by microbiota. , 2013, Immunity.
[62] J. Goedert,et al. Fecal microbial determinants of fecal and systemic estrogens and estrogen metabolites: a cross-sectional study , 2012, Journal of Translational Medicine.
[63] E. Weeber,et al. APOE4-specific Changes in Aβ Accumulation in a New Transgenic Mouse Model of Alzheimer Disease* , 2012, The Journal of Biological Chemistry.
[64] M. Surette,et al. The interplay between the intestinal microbiota and the brain , 2012, Nature Reviews Microbiology.
[65] Rob Knight,et al. Defining the human microbiome. , 2012, Nutrition reviews.
[66] C. Schadt,et al. Massively parallel rRNA gene sequencing exacerbates the potential for biased community diversity comparisons due to variable library sizes. , 2012, Environmental microbiology.
[67] G. Macfarlane,et al. Bacteria, colonic fermentation, and gastrointestinal health. , 2012, Journal of AOAC International.
[68] H. Dupont,et al. The intestinal microbiota and chronic disorders of the gut , 2011, Nature Reviews Gastroenterology &Hepatology.
[69] V. Leoni. The effect of apolipoprotein E (ApoE) genotype on biomarkers of amyloidogenesis, tau pathology and neurodegeneration in Alzheimer's disease , 2011, Clinical chemistry and laboratory medicine.
[70] Witold R. Rudnicki,et al. Feature Selection with the Boruta Package , 2010 .
[71] William A. Walters,et al. QIIME allows analysis of high-throughput community sequencing data , 2010, Nature Methods.
[72] F. Bushman,et al. QIIME allows integration and analysis of high-throughput community sequencing data. Nat. Meth. , 2010 .
[73] R. Mayeux,et al. Use of genetic variation as biomarkers for mild cognitive impairment and progression of mild cognitive impairment to dementia. , 2010, Journal of Alzheimer's disease : JAD.
[74] Patrice D Cani,et al. The role of the gut microbiota in energy metabolism and metabolic disease. , 2009, Current pharmaceutical design.
[75] M. Ohno,et al. Intraneuronal β-Amyloid Aggregates, Neurodegeneration, and Neuron Loss in Transgenic Mice with Five Familial Alzheimer's Disease Mutations: Potential Factors in Amyloid Plaque Formation , 2006, The Journal of Neuroscience.
[76] J. Doré,et al. Differences in Fecal Microbiota in Different European Study Populations in Relation to Age, Gender, and Country: a Cross-Sectional Study , 2006, Applied and Environmental Microbiology.
[77] Eoin L. Brodie,et al. Greengenes, a Chimera-Checked 16S rRNA Gene Database and Workbench Compatible with ARB , 2006, Applied and Environmental Microbiology.
[78] Charles DeCarli,et al. Sex, Apolipoprotein E ε4 Status, and Hippocampal Volume in Mild Cognitive Impairment , 2005 .
[79] Charles DeCarli,et al. Sex, apolipoprotein E epsilon 4 status, and hippocampal volume in mild cognitive impairment. , 2005, Archives of neurology.
[80] H. Braak,et al. The Biphasic Relationship between Regional Brain Senile Plaque and Neurofibrillary Tangle Distributions: Modification by Age, Sex, and APOE Polymorphism , 2004, Annals of the New York Academy of Sciences.
[81] Hilde van der Togt,et al. Publisher's Note , 2003, J. Netw. Comput. Appl..
[82] E. L. Mortensen,et al. A gender difference in the association between APOE genotype and age-related cognitive decline , 2001, Neurology.
[83] G. Maestre,et al. Modulation by age and gender of risk for Alzheimer's disease and vascular dementia associated with the apolipoprotein E-ε4 allele in Latin Americans: findings from the Maracaibo Aging Study , 2001, Neuroscience Letters.
[84] Ø. Hammer,et al. PAST: PALEONTOLOGICAL STATISTICAL SOFTWARE PACKAGE FOR EDUCATION AND DATA ANALYSIS , 2001 .
[85] K. R. Clarke,et al. Change in marine communities : an approach to statistical analysis and interpretation , 2001 .
[86] O Hammer-Muntz,et al. PAST: paleontological statistics software package for education and data analysis version 2.09 , 2001 .
[87] A Hofman,et al. Gender differences in the incidence of AD and vascular dementia , 1999, Neurology.
[88] C. Finch,et al. Evidence for an interaction between apolipoprotein E genotype, gender, and Alzheimer disease. , 1999, Alzheimer disease and associated disorders.
[89] K. Welsh-Bohmer,et al. APOE-ε4 count predicts age when prevalence of AD increases, then declines , 1999, Neurology.
[90] B W Wyse,et al. APOE-epsilon4 count predicts age when prevalence of AD increases, then declines: the Cache County Study. , 1999, Neurology.
[91] N. Maeda,et al. Type III hyperlipoproteinemia and spontaneous atherosclerosis in mice resulting from gene replacement of mouse Apoe with human Apoe*2. , 1998, The Journal of clinical investigation.
[92] Y. Agid,et al. Apolipoprotein E ϵ4 Allele and Familial Aggregation of Alzheimer Disease , 1998 .
[93] Y. Agid,et al. Apolipoprotein E epsilon4 allele and familial aggregation of Alzheimer disease. , 1998, Archives of neurology.
[94] J. Haines,et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. , 1997, JAMA.
[95] J. Haines,et al. Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease: A Meta-analysis , 1997 .
[96] B. Hyman,et al. Apolipoprotein E and cognitive change in an elderly population , 1996, Annals of neurology.
[97] E M Wijsman,et al. Gender difference in apolipoprotein E-associated risk for familial Alzheimer disease: a possible clue to the higher incidence of Alzheimer disease in women. , 1996, American journal of human genetics.
[98] P. de Knijff,et al. Genetic heterogeneity of apolipoprotein E and its influence on plasma lipid and lipoprotein levels , 1994, Human mutation.
[99] K. Weisgraber. Apolipoprotein E: structure-function relationships. , 1994, Advances in protein chemistry.
[100] K. R. Clarke,et al. Non‐parametric multivariate analyses of changes in community structure , 1993 .
[101] J. Dallongeville,et al. Modulation of plasma triglyceride levels by apoE phenotype: a meta-analysis. , 1992, Journal of lipid research.
[102] C. Sing,et al. Apolipoprotein E polymorphism and atherosclerosis. , 1988, Arteriosclerosis.